Top

International Journal of Colorectal Disease

Published in:

01-09-2020 | Radiotherapy | Review

Outcome following local excision of T1 anal cancers—a systematic review

Authors: T. B. Pedersen, J. Kildsig, E. Serup-Hansen, P. Gocht-Jensen, M. F. Klein

Published in: International Journal of Colorectal Disease | Issue 9/2020

Abstract

Purpose

In most cases, squamous cell carcinoma of the anus (SCCA) is treated with chemo-radiotherapy preserving sphincter function and offering good long-term survival and low recurrence rates. However, chemo-radiotherapy has several side effects: dyspareunia, impotence, fecal incontinence, pain, and skin symptoms. Small/T1 tumors, without metastatic disease, can be treated with local excision alone. We aimed to systematically review the literature regarding outcome following local excision of T1 SCCA.

Methods

PubMed and Embase databases were searched for studies that investigated outcome following local excision of SCCA.

Results

Twenty-three studies were included. Twenty of the studies were retrospective, and three studies included more than 100 patients. Most of the studies were published before the 1980s. Overall there was great heterogeneity and missing data across the included studies when comparing patient demographics, resection margins, definitions on tumor location, and outcome.

Overall 5-year survival was 69% (95% CI 66–72) following local excision. Overall 5-year recurrence was 37% (95% CI 30–45) following local excision. No complications were reported following local excision.

Conclusion

The current literature on outcome following local excision of T1 anal cancers consists predominantly of smaller, retrospective, and heterogenous studies. Overall 5-year survival is acceptable, but worse than following chemo-radiation therapy. However, local excision seems to have no or only few minor complications. Recurrence rates are high. Therefore, a thorough follow-up program is needed when performing local excision as primary treatment for T1 SCCA. There is an evident need for further studies.

Nigro ND, Vaitkevicius VKCBJ (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17(3):354–356CrossRef

Geh I, Gollins S, Renehan A, Scholefield J, Goh V, Prezzi D et al (2017) Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017). Anal Cancer 19:82–97

Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol 111(3):330–339 Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24947004&retmode=ref&cmd=prlinks%0Apapers3://publication/doi/10.1016/j.radonc.2014.04.013 CrossRef

James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial. Lancet Oncol 14(6):516–524CrossRef

Bentzen AG, Balteskard L, Wanderås EH, Frykholm G, Wilsgaard T, Dahl O, Guren MG (2013) Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors. Acta Oncol (Madr) 52(4):736–744CrossRef

Sunesen KG, Nørgaard M, Lundby L, Havsteen H, Buntzen S, Laurberg S (2015) Long-term anorectal , urinary and sexual dysfunction causing distress after radiotherapy for anal cancer: a Danish multicentre cross-sectional questionnaire study. 6–10

Joseph K, Vos LJ, Warkentin H, Paulson K, Polkosnik L (2016) Anne, Usmani N, et al. Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer. Radiother Oncol 120(2):228–233. https://doi.org/10.1016/j.radonc.2016.06.020 CrossRefPubMed

Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK et al (2018) Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology. JNCCN J Natl Compr Cancer Netw 16(7):852–871CrossRef

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012CrossRef

10.

Ottawa Hospital Research Institute. [cited 2019 Oct 8]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

11.

Cortese AF (1975) Surgical approach for treatment of epidermoid anal carcinoma. Cancer. 36(5):1869–1875CrossRef

12.

Dillard BM. Epidermoid cancer of anal margin and canal. Arch Surg. 1963 [cited 2019 Oct 9];86(5):772. Available from: http://archsurg.jamanetwork.com/article.aspx?doi=10.1001/archsurg.1963.01310110082012

13.

Merlini M, Eckert P (1985) Malignant tumors of the anus. A study of 106 cases. Am J Surg 150(3):370–372CrossRef

14.

Jensen SL, Hagen K, Harling H, Shokouh-Amiri MH, Nielsen O V. Long-term prognosis after radical treatment for squamous-cell carcinoma of the anal canal and anal margin. Dis Colon Rectum. 1988 [cited 2019 Oct 8];31(4):273–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3359896

15.

Stearns MW, Quan SH. Epidermoid carcinoma of the anorectum. Surg Gynecol Obstet. 1970 [cited 2019 Oct 9];131(5):953–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/5471546

16.

Golden GT, Horsley JS. Surgical management of epidermoid carcinoma of the anus. Am J Surg. 1976 [cited 2019 Oct 8];131(3):275–80. Available from: https://linkinghub.elsevier.com/retrieve/pii/000296107690115X

17.

Pintor MP, Northover JMA, Nicholls RJ. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984. Br J Surg. 1989 [cited 2019 Oct 9];76(8):806–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2765832

18.

Boman BM, Moertel CG, O’Connell MJ, Scott M, Weiland LH, Beart RW, et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer. 1984 [cited 2019 Oct 8];54(1):114–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6326995

19.

Greenall MJ, Quan SH, Stearns MW, Urmacher C, DeCosse JJ. Epidermoid cancer of the anal margin. Pathologic features, treatment, and clinical results. Am J Surg. 1985 [cited 2019 Oct 9];149(1):95–101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3966647

20.

Al-Jurf AS, Turnbull RP, Fazio VW. Local treatment of squamous cell carcinoma of the anus. Surg Gynecol Obstet. 1979 Apr [cited 2019 Oct 8];148(4):576–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/432774

21.

Bohe M, Lindström C, Ekelund G, Leandoer L. Carcinoma of the anal canal. Scand J Gastroenterol. 1982 [cited 2019 Oct 9];17(6):795–800. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7156875

22.

Christiansen J, Vittrup M. Squamous-cell carcinoma of the anus. Acta Chir Scand. 1975 [cited 2019 Oct 9];141(6):554–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/52964

23.

CUTHBERTSON AM, Kaye AH. Local excision of carcinomas of the rectum, anus, and anal canal. ANZ J Surg. 1978 [cited 2019 Oct 8];48(4):412–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/282874

24.

Hardy KJ, Hughes ESR, Cuthbertson AM. Squamous cell carcinoma of the anal canal and anal margin. Aust N Z J Surg. 1969 [cited 2019 Oct 8];38(4):301–5. Available from: http://doi.wiley.com/10.1111/j.1445-2197.1972.tb05642.x

25.

Lorenz HP, Wilson W, Leigh B, Crombleholme T, Schecter W. Squamous cell carcinoma of the anus and HIV infection. Dis Colon Rectum. 1991 [cited 2019 Oct 8];34(4):336–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2007351

26.

Alfa-Wali M, Dalla Pria A, Nelson M, Tekkis P, Bower M (2016) Surgical excision alone for stage T1 anal verge cancers in people living with HIV. Eur J Surg Oncol 42(6):813–816. https://doi.org/10.1016/j.ejso.2016.02.253 CrossRefPubMed

27.

Chakrabarti S, Jin Z, Huffman BM, Yadav S, Graham RP, Lam-Himlin DM, Lightner AL, Hallemeier CL, Mahipal A (2019) Local excision for patients with stage I anal canal squamous cell carcinoma can be curative. J Gastrointest Oncol 10(2):171–178CrossRef

28.

Deshmukh AA, Zhao H, Das P, Chiao EY, You YQN, Franzini L et al (2018) Clinical and economic evaluation of treatment strategies for T1N0 anal canal cancer. Am J Clin Oncol Cancer Clin Trials 41(7):626–631CrossRef

29.

Leon O, Hagberg O, Johnsson A (2018) Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin. Acta Oncol (Madr) 57(9):1209–1215. https://doi.org/10.1080/0284186X.2018.1442931 CrossRef

30.

Suradkar K, Pappou EE, Lee-Kong SA, Feingold DL, Kiran RP, Merlini M et al (2018) Anal canal squamous cell cancer: are surgical alternatives to chemoradiation just as effective? Am J Surg 38(3):965–972. https://doi.org/10.1016/j.ejso.2016.02.253 CrossRef

31.

Chai CY, Cao HT, Awad S, Massarweh NN (2018) Management of stage i squamous cell carcinoma of the anal canal. JAMA Surg 153(3):209–215CrossRef

32.

Gao X, Goffredo P, Kahl AR, Charlton ME, Weigel RJ, Hassan I. Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: a population-based analysis. Eur J Surg Oncol. 2020;(xxxx). Available from: https://doi.org/10.1016/j.ejso.2020.03.003

33.

Arana R, Fléjou JF, Si-Mohamed A, Bauer P, Etienney I (2015) Clinicopathological and virological characteristics of superficially invasive squamous-cell carcinoma of the anus. Color Dis 17(11):965–972CrossRef

34.

Youssef I, Osborn V, Lee A, Katsoulakis E, Kavi A, Choi K, Safdieh J, Schreiber D (2019) Survival benefits and predictors of use of chemoradiation compared with radiation alone for early stage (T1-T2N0) anal squamous cell carcinoma. J Gastrointest Oncol. 10(4):616–622CrossRef

35.

Sunesen KG, Buntzen S, Tei T, Lindegaard JC, Nørgaard M, Laurberg S. Perineal healing and survival after anal cancer salvage surgery: 10-year experience with primary perineal reconstruction using the vertical rectus abdominis myocutaneous (VRAM) Flap. 2009;68–77

36.

ISRCTN - ISRCTN88455282: PLATO - personalising anal cancer radiotherapy dose. [cited 2019 Oct 8]. Available from: http://www.isrctn.com/ISRCTN88455282

Title: Outcome following local excision of T1 anal cancers—a systematic review
Authors: T. B. Pedersen
J. Kildsig
E. Serup-Hansen
P. Gocht-Jensen
M. F. Klein
Publication date: 01-09-2020
Publisher: Springer Berlin Heidelberg
Keywords: Radiotherapy
Cytostatic Therapy
Anal Cancer
Anal Cancer
Published in: International Journal of Colorectal Disease / Issue 9/2020
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-020-03687-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Outcome following local excision of T1 anal cancers—a systematic review

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2020

Trends in incidence, mortality rates, and survival of colorectal cancer in Western Australia from 1990 to 2014: a retrospective whole-population longitudinal study

Impact of anaemia at discharge following colorectal cancer surgery

Clinical outcome for management of colonic diverticulitis: characteristics and surgical factor based on two institution data at South Korea

Predictive factors of complete pathological response in patients with locally advanced rectal cancer

Endoscopic management of postoperative anastomotic bleeding in patients with colorectal cancer

The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis